期刊
ONCOTARGET
卷 7, 期 16, 页码 22474-22485出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.7965
关键词
stroke; cell membrane repair; neuroprotection; TRIM72; tissue plasminogen activator
资金
- National Natural Science Foundation of China [31430043, 81400256]
- National Basic Research Program of China [2012CB517801, 2013CB531104]
- National Institutes of Health [RO1-AR061385, RO1-AG028614, RO1-HL069000, RO1-AR057404]
- American Heart Association [12SDG12070174]
Ischemic injury to neurons represents the underlying cause of stroke to the brain. Our previous studies identified MG53 as an essential component of the cell membrane repair machinery. Here we show that the recombinant human (rh) MG53 protein facilitates repair of ischemia-reperfusion (IR) injury to the brain. MG53 rapidly moves to acute injury sites on neuronal cells to form a membrane repair patch. IR-induced brain injury increases permeability of the blood-brain-barrier, providing access of MG53 from blood circulation to target the injured brain tissues. Exogenous rhMG53 protein can protect cultured neurons against hypoxia/reoxygenation-induced damages. Transgenic mice with increased levels of MG53 in the bloodstream are resistant to IR-induced brain injury. Intravenous administration of rhMG53, either prior to or after ischemia, can effectively alleviate brain injuries in rats. rhMG53-mediated neuroprotection involves suppression of apoptotic neuronal cell death, as well as activation of the pro-survival RISK signaling pathway. Our data indicate a physiological function for MG53 in the brain and suggest that targeting membrane repair or RISK signaling may be an effective means to treat ischemic brain injury.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据